Health care professionals can have a powerful impact on labeling requirements for drugs by formally petitioning the FDA for ...

Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs)demonstrate ...

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs) demonstrate durable seizure reductions, including increases in ...

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

Developed the world's first multimodal brain signal-based model capable of learning without simultaneous EEG and fNIRS measurements. - Self-learning from data of hundreds of individuals... Introducing ...

The U.S. Food and Drug Administration has approved an updated label for Unloxcyt (cosibelimab-ipdl) for the treatment of ...

Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire ...

The Food and Drug Administration (FDA) has approved updated labeling for Unloxcyt™ (cosibelimab-ipdl) for the treatment of adults with metastatic ...

This article was reviewed by Sara Harcharik Perkins, MD. Spironolactone for Hair Loss: Benefits, Dosage, and Risks Key ...

Clear recognition of high unmet need and urgency for the SCN2A community and plausibility of the mechanism of elsunersen FDA agreed to proposed ...

BeOne Medicines AG is rated Strong Buy as Brukinsa and Tevimbra drive robust growth and pipeline catalysts approach. Learn ...